An artificial intelligence (AI) deep learning tool that estimates the malignancy risk of lung nodules achieved high cancer detection rates while significantly reducing false-positive results.

Dr. Joshua K. Sabari sat down with Terri Conneran at the 2025 World Conference on Lung Cancer for a conversation on the importance of biomarker testing.

An artificial intelligence (AI) deep learning tool that estimates the malignancy risk of lung nodules achieved high cancer detection rates while significantly reducing false-positive results.

An artificial intelligence (AI) deep learning tool that estimates the malignancy risk of lung nodules achieved high cancer ...

This type of cancer is known as one of the most aggressive and deadliest forms of cancer. Small-cell lung cancer begins in the breathing tubes and grows quickly, creating tumors and spreading in the ...

During our third Respiratory Day last week, our Lung Health Champions travelled from across the country to Washington, D.C., ...

Lung cancer is a significant global health challenge, continuing to be the leading cause of cancer-related mortality worldwide. It contributes to ...

HEALTHWAY Cancer Care Hospital of AC Health, the health care arm of the Ayala Group, has partnered with pharmaceutical firm AstraZeneca to launch a lung center that is expected to provide services ...

The Ayala Group has teamed up with AstraZeneca in establishing the country’s leading health facility for detection and treatment of lung illnesses, particularly cancer. Healthway Cancer Care Hospital ...

A mobile lung cancer screening unit will be brought to the Two Virginias Health Fair in October 2025 to bring attention to ...

Ultimately, in consultation with her oncologist, Katie selected ALUNBRIG ® (brigatinib) as her first-line treatment option, ...

Thailand is enhancing its healthcare system by integrating artificial intelligence (AI) into early-stage lung cancer ...